Evidence map›Paper›PMID 38150285›Full record

Trial reportCancer2024

Longitudinal adherence to annual colorectal cancer screening among Black persons living in the United States enrolled in a community-based randomized trial.

Mariana Arevalo, Steven K Sutton, Rania Abdulla, Shannon M Christy, Cathy D Meade, Richard G Roetzheim, Clement K Gwede

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Monitoring of Colorectal Cancer Screening Adherence Among African American Patients of North Florida Community Health Centers.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mariana ArevaloDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA.ORCID 0000-0001-5825-532X
Steven K SuttonDepartment of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida, USA.ORCID 0000-0002-2504-7601
Rania AbdullaNTRO Non-Therapeutic Research Office, Moffitt Cancer Center, Tampa, FL, USA.
Shannon M ChristyDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA.ORCID 0000-0001-5306-7020
Cathy D MeadeDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA.ORCID 0000-0001-6422-8248
Richard G RoetzheimDepartment of Family Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.
Clement K GwedeDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, USA.ORCID 0000-0003-1630-7333
University of South Florida · USMoffitt Cancer Center · US

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI John L. Cleveland · 1998 to 2026
$93.5M
Behavioral Oncology Education & Career DevelopmentR25CA090314 · NCI · H. LEE MOFFITT CANCER CTR &RES INST · PI BRANDON, THOMAS H · 2003 to 2018
$4.0M
NCI NIH HHS P30 CA076292NCI NIH HHS P30-CA076292NCI NIH HHS R25 CA090314NCI NIH HHS R25CA090314
6 · The paper itself

Abstract

backgroundThis study examined repeat colorectal cancer screening rates at 12 and 24 months as part of a randomized intervention trial among Black persons living in the United States and factors associated with screening adherence.

methodsParticipants completed a survey assessing demographics and Preventive Health Model (PHM) factors (e.g., self efficacy, susceptibility) and received either a culturally targeted photonovella plus free fecal immunochemical test (FIT) kits (intervention group) or a standard educational brochure plus free FIT kits (comparison group). FIT return was assessed at 6, 12, and 24 months. Descriptive statistics summarized patterns of repeat screening. Logistic regression models assessed FIT uptake overtime, and demographic and PHM factors associated with screening adherence.

resultsParticipants (N = 330) were U.S.-born (93%), non-Hispanic (97%), and male (52%). Initial FIT uptake within 6 months of enrollment was 86.6%, and subsequently dropped to 54.5% at 12 months and 36.6% at 24 months. Higher FIT return rates were observed for the brochure group at 24 months (51.5% vs 33.3% photonovella, p = .023). Multiple patterns of FIT kit return were observed: 37% completed FIT at all three time points (full adherence), 22% completed two of three (partial adherence), 29% completed one of three (partial adherence), and 12% did not return any FIT kits (complete nonadherence). Predictors of full adherence were higher levels of education and self-efficacy.

conclusionsFull adherence to repeat screening was suboptimal. Most participants had partial adherence (one or two of three) to annual FIT screening. Future studies should focus on strategies to support repeat FIT screening.

Indexed as

Colorectal NeoplasmsEarly Detection of CancerBlack or African AmericanFemaleHumansMaleMass ScreeningOccult BloodPatient ComplianceUnited Statescancer screeningcolorectal cancer screeningfecal immunochemical testFIThealth behaviorlongitudinal studypsychosocial factorsrepeat screeningstool blood test

Identifiers

PMID38150285
PMCPMC11009071
OpenAlexW4390265604

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.